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Abstract: Benzene is used as a general purpose solvent. Benzene metabolism starts from phenol and ends with 
p-benzoquinone and o-benzoquinone. Liver injury inducted by benzene still remains a toxicologic problem. Tumor related 
genes and immune responsive genes have been studied in patients suffering from benzene exposure. However, gene 
expression proﬁ  les and pathways related to its hepatotoxicity are not known. This study reports the results obtained in 
the liver of BALB/C mice (SLC, Inc., Japan) administered 0.05 ml/100 g body weight of 2% benzene for six days. Serum, 
ALT, AST and ALP were determined using automated analyzer (Fuji., Japan). Histopathological observations were made 
to support gene expression data. c-DNA microarray analyses were performed using Affymetrix Gene-chip system. After 
six days of benzene exposure, twenty ﬁ  ve genes were down regulated whereas nineteen genes were up-regulated. These 
gene expression changes were found to be related to pathways of biotransformation, detoxiﬁ  cation, apoptosis, oxidative 
stress and cell cycle. It has been shown for the ﬁ  rst time that genes corresponding to circadian rhythms are affected by 
benzene. Results suggest that gene expression proﬁ  le might serve as potential biomarkers of hepatotoxicity during benzene 
exposure.
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Introduction
Benzene is widely used as a general purpose industrial solvent. However, it is now used principally 
in the synthesis of other chemicals. Its toxic effects on the blood and bone marrow include leuco-
penia, pancytopenia, aplastic anemia and leukemia (Snyder, 2002). Several studies on benzene 
have focused on its metabolic pathways to determine its hematotoxicity and leukemogenicity 
(Henderson, 1996; Snyder and Hedli, 1996). Metabolism of benzene to reactive metabolites by 
hepatic enzymes mainly cytochrome P4502E1 (CYP2E1) is a prerequisite to its cyto and genotoxic-
ity (Gut et al. 1996; Valentine et al. 1996). Primary benzene metabolites include phenol, hydro-
quinone, catechol and trans trans muconic acid (Ross, 2000). They interact synergistically and 
further exacerbate benzene toxicity (Chen and Eastmond, 1995). This mechanism of multime-
tabolite genotoxicity is another unique aspect of benzene that distinguishes it from other chemicals 
in terms of mechanism of its toxicity. Subsequent secondary activation of its metabolites by myelo-
peroxidase (MPO) present in bone marrow results in the production of genotoxic quinines and 
reactive oxygen species. They induce hemopoetic cellular damage and dysfunction of bone marrow 
stromal cells (Farris et al. 1997). Despite intensive studies over several decades, mechanisms 
underlying benzene induced toxicity and leukemogenicity are not yet fully understood. They are 
complicated by various pathways including those of metabolism (Snyder and Hedli, 1996), growth 
factor regulation (Niculescu, 1995), oxidative stress (Laskin et al. 1996), DNA damage (Lee and 
Garner, 1991), cell cycle regulation (Yoon et al. 2001b) and programmed cell death (Ross et al. 
1996). To elucidate molecular mechanisms of its toxicity, cDNA microarray analyses have been 
performed by several workers. Yoon et al. (2003) performed cDNA microarray analysis to study 
the mechanisms of benzene induced hematotoxicity in bone marrow of mouse. Effects of oral 
exposure to benzene on gene expression in rat liver were reported by Heijne et al. (2005). Gene 
expression changes were attributed to pathways of biotransformation viz. glutathione synthesis, 
fatty acid and cholesterol metabolism. Kim et al. (2005) suggested that hydroquinone at least in 192
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part, may enhance allergic immune responses of 
benzene by inhibiting the production of IL-12 
in macrophages. Microarray analysis of periph-
eral blood of benzene exposed workers was 
performed by Forrest et al. (2005). They showed 
that the altered expression of CXCL16, ZNF331, 
JUN and PF4 as potential biomarkers of benzene 
exposure. Tumor related (Xia et al. 2005) and 
immune responsive genes (Wang et al. 2005) 
have also been recorded in patients suffering 
from benzene poisoning.
Since global gene expression studies are now 
being increasingly used in toxicology (Waters, 
et al. 2003), we hypothesized that microarrays 
could identify changes in gene expression in the 
liver that could be used as new biomarkers of 
exposure, identify early effects and provide 
information on mechanism of benzene toxicity. In 
this study we investigated the changes in gene 
expression induced by 24 hrs and six days of 
exposure to benzene in the liver of mice to probe 
further molecular mechanisms of benzene toxicity. 
The overall objective of the study is to identify 
potential molecular markers of early effects of 
benzene in liver.
Materials and Methods
Chemicals
Benzene was purchased from Sigma-Aldrich 
(U.S.A.). Trizol was purchased from Invitrogen 
(U.S.A.). RNA isolation kit was procured from 
Qiagen (Germany).
Animals and treatments
Approximately 9-week old, male BALB/c mice 
(SLC, Inc., Japan) were kept in a 12 h light/dark 
cycle under controlled temperature and humidity 
for 2 weeks in the animal room prior to the exper-
iment. The mice were offered standard food pellets 
and water ad libitum. Their body weight averaged 
from 24 to 27 g (mean ± S.D. –25.75 ± 0.97).
Pure benzene (99%) was diluted by corn oil so 
as to make a 2% (v/v) solution of benzene in corn 
oil. 0.05 ml of diluted benzene/100 g body weight 
was intraperitoneally injected to mice. 5 benzene 
treated mice were sacriﬁ  ced after 24 h of benzene 
treatment. While 5 were sacriﬁ  ced after 6 days of 
benzene treatment. Parallel controls were also 
sacriﬁ  ced simultaneously.
Biochemical analysis
Blood was collected from the inferior vena cava. 
Serum was separated by centrifugation. Serum 
activities of alanine aminotransferase (ALT), aspar-
tate aminotransferase (AST) and alkaline phospha-
tase (ALP) were determined using automated 
Clinical Chemistry Analyzer (Fuji Dri-Chem 
3500s, Fujiﬁ  lm Co., Japan) at each time point. Data 
was statistically calculated and signiﬁ  cance differ-
ence between treated and control groups was tested 
using one way analysis of variance (ANOVA) fol-
lowed by the Dunnett test. P values less than 0.05 
were considered to be signiﬁ  cant.
Histopathology
Small pieces of liver collected from the mid liver 
lobe of all treated and control mice were ﬁ  xed in 
10% neutral buffered formalin, dehydrated in 
alcohol, cleared in xylene and embedded in paraf-
fin. Four microns thick paraffin sections thus 
prepared using rotary microtome (2165, Leica, 
Germany) were stained with hematoxylin and eosin 
and examined under light microscope (E400, 
Nikon, Japan).
Isolation of RNA
Liver samples were homogenized with 2 ml Trizol
® 
(Invitrogen, U.S.A.) and mixed with 0.4 ml chlo-
roform. Following centrifugation, aqueous phase 
was collected and mixed with isopropanol for pre-
cipitation. RNA precipitate was washed by ethanol. 
Isolated total RNA was puriﬁ  ed using RNeasy mini 
kit (Qiagen, Germany) according to the manufac-
turer’s protocol. The total RNA was quantiﬁ  ed 
using NanoDrop
® ND-1000 (NanoDrop, U.S.A.) 
and RNA integrity was determined by Agilent 
Bioanalyzer 2100 (Agient Technologies, U.S.A.).
Microarray analysis
Affymetrix GeneChip
® Mouse 430A 2.0 contain-
ing over 22,600 probe sets was used for microarray 
experiment. Double-stranded cDNA was synthe-
sized from 5 ug of template total RNA using One-
Cycle cDNA Synthesis kit (Affymetrix, U.S.A.), 
and biotin labeled cRNA was synthesized using 
IVT Labeling kit (Affymetrix, U.S.A.). The 
labeled cRNA was purified with GeneChip
® 
Sample Cleanup Module (Affymetrix, U.S.A.). 
The quality and quantity of the cRNA was checked 
by conducting gel electrophoresis and NanoDrop
® 193
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ND-1000 (NanoDrop, U.S.A.), respectively. Fifteen 
micrograms of the puriﬁ  ed cRNA of each sample 
was fragmented and hybridized to arrays for 16 h 
at 45 °C. All arrays were washed and stained auto-
matically by using a fluidics Station 450 
(Affymetrix, U.S.A.) and scanned by GeneChip
® 
scanner 3000 (Affymetrix, Inc, U.S.A.). All pro-
cedures were performed according to the manufac-
turer’s protocols (Affymetrix, U.S.A.). Image 
processing was performed using Affymetrix 
GeneChip
® Operating System (GCOS).
Gene expression analysis
The preprocessing procedure of resultant cell 
intensity files (CEL) and following statistical 
analysis were performed using GenePlex software 
version 2.3 (ISTECH Inc., Korea). Microarray data 
was globally normalized and used for further 
analysis. Total 22,600 probe sets representing over 
14,000 mouse genes were applied to gene expres-
sion analysis as well as hierarchical clustering. The 
differentially expressed genes were selected at a 
minimum 2-fold change after 1 day and 6 days of 
benzene treatment compared with the control 
group. Data were statistically analyzed by Student’s 
t-test and P-values 0.01 were considered as 
statistically signiﬁ  cant. The selected genes were 
ﬁ  ltered by extension GCOS ﬁ  ltering (reference 
M1). In addition, the differentially expressed genes 
at 6 days treatment group compared with 1day 
treatment group were also selected considering the 
same criteria (2-fold, P  0.01). All selected 
genes were analyzed by two-dimensional hierarchi-
cal clustering based on Pearson correlation and 
Complete Linkage (Eisen, 1998). Discrepancies 
among control, 1 day, and 6 days group were visu-
alized by Principal Component Analysis (PCA). 
The classiﬁ  cation of pathway for interesting genes 
was performed using KEGG pathway database. 
The selected genes were annotated based on 
NetAffx, linked at http://www.affymetrix.com.
Results
Blood biochemistry
Aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) values increased signiﬁ  -
cantly after 24 hours of benzene treatment. How-
ever, on treatment for 6 days, a signiﬁ  cant decline 
in their activity was recorded. Activity of serum 
alkaline phosphatase also increased after 24 hours 
but declined after six days of benzene treatment 
(Fig. 1).
Liver histopathology
Hepatocytes near the centrilobular regions of the 
lobule were compared in all the three groups. No 
significant histopathological changes were 
observed in the liver of mice treated with benzene 
for 6 days. However, hypertrophic lesions were 
recorded at a few places (Fig. 4). However, micro-
balooning in the hepatocytes was observed in the 
liver of mice after 24 hr of benzene treatment. 
Large necrotic spaces were wanting (Fig. 3). No 
pathological lesions were observed in the liver of 
control mice (Fig. 2).
Gene expression proﬁ  le
Microarray analysis was carried out to determine 
differences in hepatic gene expression between 
benzene and vehicle (corn oil) treated mice. RNA 
integrity was intact (data not shown). Individual 
liver samples from treated animals were analysed. 
Array based observations were made in triplicate. 
Gene expression was analyzed only in animals 
treated with benzene for 24 hours and 6 days.
A total of 136 reliable genes were ﬁ  ltered from 
22600 probe sets by standard deviation of control 
strength after per spot and per chip normalization. 
Genes were sorted according to Student’s “t” test 
(P values from 0 to 0.05). Forty four genes were 
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Figure 1. Serum levels of aspartate amino transferase (AST), alanine 
amino transferase (ALT) and alkaline phosphatase (ALP) after treat-
ment with benzene at two time points i.e. one day and six days.194
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selected based on the fold difference in at least three 
of nine conditions using ANOVA. A summary of 
these analyses is presented in table 1. Table 2 lists 
genes that changed signiﬁ  cantly (p  0.05→0.01) 
in mice liver treated with benzene for six consecu-
tive days. Results exhibiting time dependent 
changes in the expression of genes corresponding 
to control mice are explained in Figure 5.
Hierarchical clustering of the genes and dura-
tion of treatment with benzene also revealed time 
dependent differences in gene expression (Fig. 5). 
Figure 6 exhibits principal component analysis 
showing gene expression changes.
Interestingly, proteins involved in biosynthesis 
of steroids (Hmger), cell cycle (Mcm5 and Mee), 
fatty and biosynthesis (Fasn), glutathione 
metabolism (Gstm3), glycerolipid metabolism 
(Lipg), glycolysis (Pklr), gluconeogenesis, MAPK 
signaling pathways (Hspa1a) and purine metabolism 
(Ecgf1) were found to be induced by benzene.
However, genes responsible for metabolism of 
xenobiotics (Cyp2b10), transcription factor 
(Gtf2ird1), cell adhesion (Cldn15 and Cldn1), cir-
cadian rhythm (Per3 and Arnt1), cytokines (Pdgfc), 
and glycine, serine and thireonine metabolism 
(Gldc) were down regulated (Table 1).
Important pathways affected after 24 hrs of 
benzene treatment included β-cell receptor signal-
ing pathways (Iﬁ  tm1), cell cycle; signaling path-
way; focal adhesion; Jak-STAT signaling pathway, 
circadian rthym (Cry1), cytokine-cytokine receptor 
interaction (Ccr5), glutathione metabolism 
(Gstm3), hematopoietic cell lineage (Cd24a) and 
TGF-beta signaling pathway (Id3 and Id1).
Analysis of pathway level
After t test and fold differences ﬁ  ltering, 44 genes 
were found to be up or down regulated by benzene 
treatment. Analysis of differentially regulated 
genes showed the involvement of calcium signal-
ing pathway, cell adhesion molecules pathway, 
circadian rhythms, glutathione-S-transferases and 
heat shock proteins in benzene toxicity.
Discussion
It has been accepted now that omic technologies 
have signiﬁ  cant potential in generating novel bio-
markers of exposure, susceptibility and response to 
different xenobiotics. Different xenobiotics produce 
HC
Figure 2. Normal hepatocytes without any atrophy or hypertrophy 
were observed in the liver of control mice. ×400.
HC
Figure 3. T.S. of the liver of a mice treated with benzene for 24 hrs 
shows microbalooning of the hepatocytes (HC). A few binucleated 
cells are also observed. ×400.
HC
Figure 4. T.S. of the liver of mice treated with benzene for 6 days 
shows no microbalooning of the hepatocytes and no paranchymal 
degradation. However, mild hypertrophy was observed at certain 
places. Enlarged nuclei are also observed. ×400.195
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Table 1. Gene expression proﬁ  le in the liver of mice affected by 6 days of benzene treatment.
Common
name
Description Average fold
change
P-Value mRNA accession
no
DOWN REGULATED
Cyp2b10 cytochrome P450,
family 2, subfamily b, 
polypeptide 10
0.281536405 0.001011593 NM_009998;
NM_009999
Gtf2ird1 general transcription 
factor III repeat domain-
containing 1
0.413325939 0.004871763 NM_020331
Avpr1a arginine vasopressin 
receptor 1A
0.324488832 0.004461284 NM_016847
Avpr1a arginine vasopressin 
receptor 1A
0.36705761 0.001599135 NM_016847
H2-Aa histocompatibility 2, class 
II antigen A, alpha
0.306047979 0.004596735 NM_010378
Cldn15 claudin 15 0.48776276 2.72E-04 NM_021719
Cldn1 claudin 1 0.260820687 5.28E-04 NM_016674
Cldn1 claudin 1 0.229626388 0.002089479 NM_016674
Clock circadian locomoter output 
cycles kaput
0.377440404 5.77E-05 NM_007715
Clock circadian locomoter output 
cycles kaput
0.424112305 0.004717732 NM_007715
Arntl aryl hydrocarbon receptor 
nuclear translocator-like
0.173296253 0.001789661 NM_007489
Pdgfc platelet-derived growth 
factor, C polypeptide
0.344610509 9.98E-04 NM_019971
Cyp4a10; 
BC013476
cytochrome P450,
family 4, subfamily a, 
polypeptide 10; cDNA 
sequence BC013476
0.065019519 5.66E-04 NM_010011;
NM_201640
Pla2g7 phospholipase A2, group 
VII (platelet-activating 
factor acetylhydrolase, 
plasma)
0.453285144 5.67E-04 NM_013737
Gldc glycine decarboxylase 0.422548113 0.001410781 NM_138595
Chka Choline kinase alpha 0.313032262 0.001080842 NM_001025566; 
NM_013490
Cd24a CD24a antigen 0.395079154 0.003244021 NM_009846
Ddc dopa decarboxylase 0.403510366 0.001461128 NM_016672
Psen2 presenilin 2 0.480851803 0.001028252 NM_011183
Mthfr 5,10-methylenetetrahydro-
folate reductase
0.312663634 6.40E-04 NM_010840
Hmox1 heme oxygenase 
(decycling) 1
0.442942648 0.008907761 NM_010442
Ecgf1 endothelial cell growth 
factor 1 (platelet-derived)
0.45767403 0.001281208 NM_138302
Sphk2 sphingosine kinase 2 0.449968706 5.78E-04 NM_020011;
NM_203280
Tjp3 tight junction protein 3 0.328536042 0.003973921 NM_013769
Tjp2 tight junction protein 2 0.494447722 0.001988285 NM_011597
(Continued)196
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Table 1. (Continued)
Common
name
Description Average fold
change
P-Value mRNA accession
no
UP REGULATED
Hmgcr 3-hydroxy-
3-methylglutaryl-
Coenzyme A reductase
2.891840187 0.001640616 NM_008255
Aacs acetoacetyl-CoA 
synthetase
2.563580176 0.003499423 NM_030210
Mcm5 minichromosome 
maintenance deﬁ  cient 5, 
cell division cycle 46
(S. cerevisiae)
2.300496316 0.003483556 NM_008566
Wee1 wee 1 homolog
(S. pombe)
7.053930707 0.001572758 NM_009516
Per2 period homolog 2 
(Drosophila)
3.369578754 0.008408468 NM_011066
Bhlhb2 basic helix-loop-helix 
domain containing, class 
B2
3.728728789 0.001394815 NM_011498
Per3 period homolog 3 
(Drosophila)
3.854051492 0.008180266 NM_011067
Fasn fatty acid synthase 2.499244207 0.001200169 NM_007988
Gstm3 glutathione S-transferase, 
mu 3
3.142999858 0.00703031 NM_010359
Lipg lipase, endothelial 2.670982122 5.59E-04 NM_010720
Pklr pyruvate kinase liver
and red blood cell
2.80962902 0.001207647 NM_013631
Pklr pyruvate kinase liver
and red blood cell
2.946723297 0.006457597 NM_013631
Pklr pyruvate kinase liver
and red blood cell
2.922004272 3.51E-04 NM_013631
Hspa1a heat shock protein 1A 8.965401248 0.00735716 NM_010479
Egfr epidermal growth factor 
receptor
2.884090081 0.005691373 NM_007912;
NM_207655
Gadd45a growth arrest
and DNA-damage-
inducible 45 alpha
2.007231563 0.008967359 NM_007836
Ppat phosphoribosyl 
pyrophosphate 
amidotransferase
2.204661449 0.001375383 XM_001002879; 
XM_001002886; 
XM_896000;
 XM_924520;
XM_973896;
XM_973937;
XM_973938;
XM_973973
Gbe1 glucan (1,4-alpha-), 
branching enzyme 1
2.143906958 0.002461176 NM_028803
Gys2 glycogen synthase 2 2.108060527 0.002009201 NM_145572197
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Table 2. Comparison of gene expression proﬁ  le in the liver of mice between two time points (One day treatment 
and six days treatment).
Common
name
Description Average fold
change
P-Value mRNA
accession
no
P4ha1 procollagen-proline, 2-oxoglutarate 
4-dioxygenase (proline 
4-hydroxylase), alpha 1 polypeptide
2.591853506 0.004172616 NM_011030
P4ha1 procollagen-proline, 2-oxoglutarate 
4-dioxygenase (proline 
4-hydroxylase), alpha 1 polypeptide
2.104156061 0.006374143 NM_011030
Iﬁ  tm1 interferon induced
transmembrane protein 1
2.049667285 1.57E-04 NM_026820
Ccnd2 cyclin D2 2.296233152 0.005968229 NM_009829
Clock circadian locomoter
output cycles kaput
0.395914404 8.26E-04 NM_007715
Cry1 cryptochrome 1 (photolyase-like) 2.016943891 0.005553137 NM_007771
Acly ATP citrate lyase 2.0650066 0.001685516 NM_134037
Ccr5 chemokine (C-C motif) receptor 5 0.448882656 0.007355149 NM_009917
Fasn fatty acid synthase 2.612494125 4.47E-04 NM_007988
Cyp4a14 cytochrome P450, family 4, subfamily 
a, polypeptide 14
0.041921708 0.004694101 NM_007822
Cyp4a10; 
BC013476
cytochrome P450, family 4, subfamily 
a, polypeptide 10; cDNA sequence 
BC013476
0.064562689 0.001113474 NM_010011;
NM_201640
Gstm3 glutathione S-transferase, mu 3 3.251600332 0.005704424 NM_010359
Pla2g7 phospholipase A2, group VII 
(platelet-activating factor 
acetylhydrolase, plasma)
0.451785594 0.001250882 NM_013737
Pklr pyruvate kinase liver
and red blood cell
2.600750828 0.001583053 NM_013631
Pklr pyruvate kinase liver
and red blood cell
3.252169263 0.00849695 NM_013631
Pklr pyruvate kinase liver
and red blood cell
2.753805631 0.003288804 NM_013631
Cd24a CD24a antigen 0.444671589 0.003072713 NM_009846
Hspa1a heat shock protein 1A 8.966809881 0.006796064 NM_010479
Hspb1 heat shock protein 1 2.349998728 0.008158746 NM_013560
Id3 inhibitor of DNA binding 3 2.42776977 2.65E-04 NM_008321
Id1 inhibitor of DNA binding 1 2.226588424 1.97E-04 NM_010495
speciﬁ  c gene expression patterns in target organs. 
Minami et al. (2005) in their study on acetamino-
phen (APAP), bromobenzene, carbontetrachloride, 
dimethylnitrosamine and thioacetamide identiﬁ  ed 
potential biomarkers of their hepatotoxicity. How-
ever, gene expression changes induced by benzene 
in the liver are yet to be established. Smith et al. 
(2005) showed that toxicogenomics have signiﬁ  cant 
potential in generating biomarkers of benzene 
toxicity. They identiﬁ  ed more than 100 differentially 
expressed genes, those related to apoptosis and 
immune function were most signiﬁ  cantly affected 
in humans occupationally exposed to benzene. 
Yoon et al. (2003) investigated benzene induced 
hematotoxicity and leukemogenicity using mouse 
bone marrow and making cDNA microarray 
analysis in C57BL/6, wild type (WT), and p53- 
knock out (KO) mice. They suggested that dysfunc-
tion of p53 gene induced fatal problems ﬁ  nally 
resulting in hemopoietic malignancies.198
Park et al
Biomarker Insights 2008:3
Similarity: 0.16
# ofclusters: 6
B
H
6
-
1
_
S
i
g
n
a
l
B
H
6
-
3
_
S
i
g
n
a
l
B
H
6
-
5
_
S
i
g
n
a
l
B
C
-
1
_
S
i
g
n
a
l
B
C
-
2
_
S
i
g
n
a
l
B
C
-
3
_
S
i
g
n
a
l
B
H
1
-
1
_
S
i
g
n
a
l
B
H
1
-
3
_
S
i
g
n
a
l
B
H
1
-
5
_
S
i
g
n
a
l
Control
Treated 1 day
Treated 6 days
Cluster 1
Cluster 2
Cluster 3
Cluster 4
Cluster 5
Cluster 6
Figure 5. Hierarchical clustering map of gene expression proﬁ  les of all selected genes at the statistical criteria of 2-fold change and 
p  0.01. Identiﬁ  cation of genes that can differentiate between 6 days and 1 day groups after benzene treatment (The gene expression 
pattern of control group shows similar to 1 day group after benzene treatment). Each row represents a gene on the microarray and each 
column represents an individual hepatic mRNA sample of mice. The red and green indicate increased and decreased expression relative to 
the control, respectively. The colored branch on each column indicates each sample group: control (Green), 1 day (blue) and 6 days (red) 
group after benzene treatment.
Benzene induced gene expression changes in 
rat liver after 28 days of oral exposure to benzene 
showed disturbances in pathways of biotransforma-
tion, glutathione synthesis, fatty acid and cholesterol 
metabolism (Heijne et al. 2005). Wang et al. (2005) 
in their study on peripheral white blood cell gene 
expression proﬁ  le of benzene poisoned patients 
identiﬁ  ed 38 genes to be associated with benzene 199
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Figure 6. Principal component analysis shows gene expression changes of 136 select genes at varying time-points. The colored circles 
represent tested groups as follows: control, Blue; 1 day group after benzene treatment, Yellow; 6 days group after benzene treatment.
toxicity. Chen et al. (2005) made cDNA microarray 
analysis of leukocytes in patients of benzene poi-
soning and found 25 genes to be differentially 
expressed. Amongst these 16 genes were up-
regulated and 9 genes were down regulated. Some 
cDNA replication and some repair genes associated 
with benzene poisoning also showed differential 
expression.
Time and dose dependent study on gene expres-
sion made by us shows that after six days of ben-
zene treatment, 44 genes were affected. 25 genes 
were down regulated and 19 genes were upregulated. 
This information was further analysed through 
KEGG pathway database. Important pathways 
affected after 24 hrs of benzene treatment included 
β-cell receptor signaling pathways (Iﬁ  tm1), cell 
cycle; signaling pathway; focal adhesion; Jak-
STAT signaling pathway, circadian rthym (Cry1), 
cytokine-cytokine receptor interaction (Ccr5), 
glutathione metabolism (Gstm3), hematopoietic 
cell lineage (Cd24a) and TGF-beta signaling path-
way (Id3 and Id1).
We for the ﬁ  rst time report that circadian rhythm 
pathway (Cry1) is also affected by benzene 
treatment. Rana et al. (2007) observed that circa-
dian rhythms effect lipid peroxidation induced by 
benzene. Susceptibility of humans and rats to ben-
zene during morning and evening was conducted 
by Leung and Harrison (1998) and Starek et al. 
(1990). Down regulation of Per3 and Arnt7 200
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observed after six days of benzene treatment clearly 
shows the inﬂ  uence of circadian rhythms on ben-
zene toxicity. Circadian rhythms are further regu-
lated by protein synthesis and we show that these 
genes too were inﬂ  uenced by benzene. Present 
report conﬁ  rms the inﬂ  uence of circadian rhythms 
on benzene hepatotoxicity. Rana and Verma (2005) 
reviewed the biochemical toxicity of benzene. 
However, this new information is expected to help 
in understanding the molecular mechanisms of 
benzene toxicity.
Interestingly, proteins involved in biosynthesis 
of steroids (Hmger), cell cycle (Mcm5 and Mee), 
fatty acid biosynthesis (Fasn), glutathione 
metabolism (Gstm3), glycerolipid metabolism 
(Lipg), glycolysis (Pklr), gluconeogenesis, MAPK 
signaling pathways (Hspa1a) and purine metabo-
lism (Ecgf1) were found to be induced by benzene. 
However, genes responsible for metabolism of 
xenobiotics (Cyp2b10), transcription factor 
(Gtf2ird1), cell adhesion (Cldn15 and Cldn1), cir-
cadian rhythm (Per3 and Arnt1), cytokines (Pdgfc), 
and glycine, serine and thireonine metabolism 
(Gldc) were down regulated (Table 1).
Biochemical and histopathological observations 
show that six days treatment with benzene encour-
aged an adaptive mechanism in the liver. Gene 
expression studies especially those of CYP2610, 
CYP4A10 that were found to be down-regulated 
ﬁ  nd support from the biochemical and histopatho-
logical results. Upregulation of Gstm3 and Hspa1a 
further suggest a protective mechanism.
The pathway analysis shows the involvement 
of calcium signaling, transferases and heat shock 
proteins in benzene toxicity. Present observations 
offer additional information on the molecular 
mechanisms of benzene toxicity. The cDNA 
microarray system showed alterations in the 
number of benzene affected genes including 
physiologic and toxicologic gene repertoires. This 
communication provides valuable targets for 
future investigations on the benzene induced 
toxicity and leukernogenicity.
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